Fox Pharma
GPhC-registered pharmacy distributing aesthetic and pharmaceutical products to qualified professionals, with own brands such as REVOLAX, Seventy Hyal 2000, VITARAN and Bellast Prime.
About Fox Pharma
Fox Pharma, pharmaceutical distribution for aesthetics professionals
Fox Pharma is a pharmacy registered with the General Pharmaceutical Council (GPhC) in the UK that sells aesthetic and pharmaceutical products exclusively to qualified professionals in the sector. The company presents itself as the official UK licence holder for REVOLAX Dermal Filler and Seventy Hyal Skin Booster, and as the exclusive UK rights holder for VITARAN Polynucleotides and Bellast Prime Dermal Filler.
Its catalogue is organised around categories such as skin boosters, polynucleotides, toxins, dermal fillers and microneedling, and also includes aesthetic consumables and supplies, weight management, chemical peels, hair rejuvenation, exosomes, PLLA stimulators, marketing materials, supplements and devices.
Own brands and exclusive portfolio
The company brings together a portfolio of exclusive products under the Fox Group umbrella. Among the brands it distributes are AUTENTICA, REVOLAX, Seventy Hyal 2000, VITARAN, Bellast Prime, KIARA, Fox Bundles, Nouveau Visage and CONTINVE. The catalogue also includes third-party brands such as Juvederm, Teosyal, Belotero, Stylage, Profhilo, Jalupro, Sunekos, Restylane, Fillmed, Plinest and Alastin.
- Seventy Hyal 2000: skin booster formulated with high molecular weight hyaluronic acid (less than 2000 kDa) that, according to the company, promotes collagen production and intense hydration.
- VITARAN: bio-revitalising injectables based on polynucleotides, aimed at reducing the appearance of periocular wrinkles by stimulating collagen and elastin.
- REVOLAX: range of dermal fillers of different viscosities to sculpt, balance and add volume to specific areas of the face.
- Bellast Prime: dermal filler presented as a new era within this category.
Responsible supply and traceability
Fox Pharma states that all products sold come from official suppliers and undergo rigorous prior checks before being added to its catalogue. The company affirms that any product licensed for syringe administration bears the CE/CA mark, which supports its quality and safety. Its responsible supply chain approach seeks to guarantee authentic and traceable products.
Training and support for clinics
In addition to product distribution, the company offers specific training for aesthetics professionals. Its offering extends to supporting clinics with the stated aim of helping them grow and succeed, combining access to products with customer service and professional standards.
Track record and positioning
With seven years of activity in the pharmaceutical sector, Fox Pharma describes itself as a trusted force in its field. The company places its mission in making quality accessible and keeping the customer at the centre of its activity, continually seeking new products and ways to improve the industry.
Corporate and regulatory information
Fox Pharma Limited operates with company registration number 11653593. The pharmacy has GPhC registration 9012072, and the superintendent pharmacist is Sanjeev Kumar Aggarwal, with GPhC number 2048806.
Distribution of aesthetic and pharmaceutical products